Drugs / Levodopa/carbidopa
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01688089 Comparator | Sep 2012 → Sep 2014 | — | Orion Corporation, Orion Pharma | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Levodopa/carbidopa | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01688089 ↗ |
| Route | Oral | “levodopa/carbidopa: oral tablet 100/25mg given four times daily for one day” NCT01688089 ↗ |